Stock FULC FULCRUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Fulcrum Therapeutics, Inc.

Equities

FULC

US3596161097

Delayed Nasdaq
Other stock markets
 20:46:41 10/05/2024 BST 		5-day change 1st Jan Change
7.43 USD -0.93% Intraday chart for Fulcrum Therapeutics, Inc. -3.94% +10.30%
05-08 Fulcrum Therapeutics, Inc. Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy in The Lancet Neurology CI
03-18 Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer MT

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FULC Stock
  4. News Fulcrum Therapeutics, Inc.
  5. MarketScreener Strategies